Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Diet with Chemotherapy in Advanced NSCLC
NCT02019979Phase 2Terminated
- Sponsor
- Mount Sinai Beth Israel
- Start
- Dec 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in non-small cell lung cancer (NSCLC), sponsored by Mount Sinai Beth Israel. Started Dec 2013; status: terminated.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02019979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02019979.